RY
Highly rated in
26
conditions
Highly rated in
26
conditions
Check Dr. Robert W. Yeh's experience treating your condition:
About Dr. Robert W. Yeh

Robert Yeh is a Cardiologist and an Interventional Cardiologist in Boston, Massachusetts. Yeh has been practicing medicine for over 20 years and is highly rated in 26 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement. He is licensed to treat patients in Massachusetts. Yeh is currently accepting new patients.

His clinical research consists of co-authoring 448 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Robert W. Yeh it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Robert W. Yeh accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
185 Pilgrim Rd, Boston, MA 02215
Background & Education
Graduate Institution
Harvard Medical School, 2003
Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in MA
Hospital Affiliations
Beth Israel Deaconess Hospital - Milton
Beth Israel Deaconess Medical Center
Lawrence General Hospital
Languages Spoken
English
Mandarin
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

Multicenter Randomized Assessment of the Firehawk™ Rapamycin TARGET Eluting Cobalt Chromium Coronary Stent System - North American Trial
Multicenter Registry of Chronic Total Occlusion Interventions
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)
Chronic Total Occlusion Percutaneous Coronary Intervention CTO-PCI Study
XIENCE 28 USA Study
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
View 8 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors